XML 11 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
BALANCE SHEETS - USD ($)
Mar. 31, 2018
Sep. 30, 2017
CURRENT ASSETS:    
Cash and cash equivalents $ 3,062,189 $ 2,369,438
Receivables 136,783 218,481
Prepaid expenses 879,592 826,429
Deposits - current portion 0 150,000
Inventory used for R&D and manufacturing 630,311 672,522
Total current assets 4,708,875 4,236,870
Plant, property and equipment, net 16,503,718 16,793,220
Patent costs, net 206,847 223,167
Deposits 1,670,917 1,670,917
Total Assets 23,090,357 22,924,174
CURRENT LIABILITIES:    
Accounts payable 7,687,172 8,196,334
Accrued expenses 902,732 936,698
Due to employees 1,054,803 693,831
Notes payable 1,176,660 994,258
Derivative instruments, current portion 20,919 10,984
Other current liabilities 14,576 12,449
Total current liabilities 10,856,862 10,844,554
Derivative instruments - net of current portion 1,835,898 2,042,418
Lease Liability 13,295,489 13,211,925
Deferred revenue 125,000 125,000
Other liabilities 35,383 37,254
Total liabilities 26,148,632 26,261,151
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' DEFICIT    
Preferred stock, $.01 par value-200,000 shares authorized; -0- shares issued and outstanding 0 0
Common stock, $.01 par value - 600,000,000 shares authorized; 16,624,552 and 11,903,133 shares issued and outstanding at March 31, 2018 and September 30, 2017, respectively 166,246 119,031
Additional paid-in capital 307,425,853 296,298,401
Accumulated deficit (310,650,374) (299,754,409)
Total stockholders' deficit (3,058,275) (3,336,977)
TOTAL LIABILITIES AND STOCKHOLDERS DEFICIT $ 23,090,357 $ 22,924,174